Fuse Biotherapeutics Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Out of Business
Fuse Biotherapeutics General Information
Description
Developer of immune-modulating therapeutics designed to treat cancers effectively. The company's platform offers a therapeutic approach that integrates multiple steps of the immune response to deliver potent and targeted treatments while preserving the natural regulatory mechanisms that protect healthy tissues, enabling patients with advanced care for cancer.
Contact Information
Website
www.fusebiotx.comCorporate Office
- 7A Henshaw Street Woburn
- Woburn, MA 01801
- United States
Corporate Office
- 7A Henshaw Street Woburn
- Woburn, MA 01801
- United States
Fuse Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 08-Jun-2026 | Completed | Out of Business | |||
| 1. Seed Round | 01-Dec-2021 | Completed | Generating Revenue |
Fuse Biotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Fuse Biotherapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Fuse Biotherapeutics Patents
Fuse Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024302041-A1 | Single-and multi-cytokine fusion proteins and uses thereof | Pending | 14-Jun-2023 | ||
| EP-4727962-A2 | Single-and multi-cytokine fusion proteins and uses thereof | Pending | 14-Jun-2023 | ||
| WO-2024259391-A2 | Single-and multi-cytokine fusion proteins and uses thereof | Inactive | 14-Jun-2023 | ||
| WO-2024259391-A3 | Single-and multi-cytokine fusion proteins and uses thereof | Inactive | 14-Jun-2023 | ||
| AU-2024265777-A1 | Methods of using il-18 fusion proteins | Pending | 02-May-2023 | C07K14/54 |
Fuse Biotherapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Fuse Biotherapeutics FAQs
-
When was Fuse Biotherapeutics founded?
Fuse Biotherapeutics was founded in 2021.
-
Where is Fuse Biotherapeutics headquartered?
Fuse Biotherapeutics is headquartered in Woburn, MA.
-
What is the size of Fuse Biotherapeutics?
Fuse Biotherapeutics has 5 total employees.
-
What industry is Fuse Biotherapeutics in?
Fuse Biotherapeutics’s primary industry is Drug Discovery.
-
Is Fuse Biotherapeutics a private or public company?
Fuse Biotherapeutics is a Private company.
-
What is Fuse Biotherapeutics’s current revenue?
The current revenue for Fuse Biotherapeutics is .
-
How much funding has Fuse Biotherapeutics raised over time?
Fuse Biotherapeutics has raised $8.18M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
